Dr. Bret L. Fisher, MD

Dr. Fisher practices at Vision Correction Center of Tuscaloosa in Tuscaloosa, Alabama.

Dr. Fisher's NPI, 1174559660, was assigned on June 25, 2006. Dr. Fisher graduated from Duke University School of Medicine in 1986. Dr. Fisher holds Florida license ME 64480.

Dr. Fisher's primary practice is Vision Correction Center of Tuscaloosa, at 1406 Mcfarlend Blvd N Suite 2b, Tuscaloosa, AL 35406. The practice phone is (205) 248-0095.

Dr. Fisher's primary practice is Vision Correction Center of Tuscaloosa in Tuscaloosa, Alabama. Dr. Fisher is also affiliated with North Mississippi Health Services-South Marion. Dmand AI also links Dr. Fisher to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fisher practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Fisher's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Fisher is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Fisher is licensed in Florida.

CMS data shows 445 Medicare services from Dr. Fisher across 9 procedure codes in 2024, for 138 Medicare patients. Medicare paid $56,381 for them.

CMS counts 138 Medicare patients who saw Dr. Fisher in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fisher's median patient age at 73, with 61% women.

In 2024, Dr. Fisher wrote 547 Medicare Part D claims for 333 patients. 77% of them were for generic drugs. CMS names the drug for 449 of them, across 5 drugs with 11 or more claims each, at $12,398 in total drug cost. In 2023, CMS named 410 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fisher for performance year 2024, reported as part of a group. Dr. Fisher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 246 procedures of cataract surgery by Dr. Fisher, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Fisher, published from 2016 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Lens Implantation, Intraocular, Phacoemulsification and Refraction, Ocular. Dr. Fisher has published most often in Clin Ophthalmol. Dr. Fisher's most frequent co-authors are Satish S. Modi, MD, Robert Paul Lehmann, MD and David John Ludwick, MD.

Dmand AI links Dr. Fisher to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Dry Eye Syndromes, Presbyopia and Lacrimal Apparatus Diseases. Surface Ophthalmics, Inc. sponsors the most, 2.

CMS Open Payments shows 560 general payments to Dr. Fisher from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Ziemer USA paid the most, $488,002. It also lists 8 research payments totaling $4,953 from 2021 to 2022.

Dr. Fisher graduated from Duke University School of Medicine in 1986.